Acorda Therapeutics Operating Cash Flow 2011-2026 | ACOR

Annual Operating Cash Flow Acorda Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-14 M	-20.9 M	-41.3 M	-61 M	-128 M	151 M	97.1 M	29.6 M	-	-	-	-	66.3 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
151 M	-128 M	8.72 M

Quarterly Operating Cash Flow Acorda Therapeutics

2024-Q1	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-20.2 M	-7.02 M	-	-30 M	-28.2 M	-13.6 M	-	-44.6 M	-35.6 M	-26.9 M	-	-62.5 M	-59.5 M	-38.8 M	-	-117 M	-92.4 M	-77.5 M	-	163 M	85 M	28.7 M	-	36.6 M	-15.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-12.1 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
163 M	-117 M	-18.4 M

Operating Cash Flow of other stocks in the Biotechnology industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-481 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	-57.8 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	-8.58 M	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	-108 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	-22.3 M	-	10.36 %	$ 9.8 M	USA
I-Mab IMAB	-1.3 B	-	-	$ 866 M	China
Genfit SA GNFT	99.9 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-23.8 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	-418 M	$ 220.53	2.32 %	$ 5 B	Danmark
Aptinyx APTX	-59.7 M	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	-6.01 M	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	156 M	$ 19.63	2.05 %	$ 918 M	USA
Applied Genetic Technologies Corporation AGTC	-65.7 M	-	-	$ 26.5 M	USA
CytomX Therapeutics CTMX	-75.6 M	$ 4.18	-1.42 %	$ 577 M	USA
Ayala Pharmaceuticals AYLA	-34.5 M	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	-7.8 M	-	-10.17 %	$ 12.2 K	USA
Atreca BCEL	-80.7 M	-	-11.76 %	$ 5.79 M	USA
Acasti Pharma ACST	-14.9 M	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	1.13 B	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	-235 M	-	-	$ 546 M	USA
Cara Therapeutics CARA	-92.1 M	-	-3.03 %	$ 260 M	USA
Adverum Biotechnologies ADVM	-92.5 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-30.3 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-29.5 M	-	-9.65 %	$ 45.9 M	USA
Avenue Therapeutics ATXI	-9.03 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	-206 M	$ 1.34	1.14 %	$ 342 M	Britain
Corbus Pharmaceuticals Holdings CRBP	-64.5 M	$ 8.33	1.83 %	$ 111 M	USA
CRISPR Therapeutics AG CRSP	-345 M	$ 47.37	2.02 %	$ 4.26 B	Schweiz
Cyclacel Pharmaceuticals CYCC	-7.99 M	-	-5.98 %	$ 34.1 M	USA
ChemoCentryx CCXI	-75.6 M	-	-	$ 3.74 B	USA
Eton Pharmaceuticals ETON	10.5 M	$ 24.01	4.53 %	$ 646 M	USA
Dynavax Technologies Corporation DVAX	66.5 M	-	-	$ 2.02 B	USA
BioDelivery Sciences International BDSI	41 M	-	-4.8 %	$ 255 M	USA
Enochian Biosciences ENOB	-7.87 M	-	-	$ 40.5 M	USA
Aeglea BioTherapeutics AGLE	-169 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-733 M	-	-	$ 867 M	Germany
Bellerophon Therapeutics BLPH	-17.8 M	-	-74.18 %	$ 955 K	USA
Akero Therapeutics AKRO	-230 M	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	-39.6 M	$ 4.46	3.36 %	$ 855 M	Canada
Homology Medicines FIXX	-33.5 M	-	0.77 %	$ 53.4 M	USA
Akouos AKUS	-63.7 M	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	-15.1 M	-	1.93 %	$ 17.4 M	USA
GT Biopharma GTBP	-12.9 M	$ 0.46	-3.14 %	$ 2.54 M	USA
Allakos ALLK	-116 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	-4.34 M	-	-5.38 %	$ 6.06 M	USA
Halozyme Therapeutics HALO	652 M	$ 63.2	1.87 %	$ 7.57 B	USA